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Abstract: Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disorder. 
This paper describes the case of a 39-year-old Sudanese male who presented to the emergency 
room with fever, jaundice, decreased level of consciousness, and worsening kidney function for 
7 days, a high lactate dehydrogenase level (1947), severe thrombocytopenia (platelets 8), and 
numerous schistocytes in the peripheral blood smear. The patient was admitted with a diagno-
sis of TTP for plasma exchange. Fourteen days later, his creatinine kinase (CK) level rose to 
.50,000 IU; rhabdomyolysis was suggested. Continuous venovenous hemodialysis (CVVHD) 
was started. The patient’s CK level remained high, despite CVVHD, until the 6th day, after 
which this parameter gradually started to decrease. This report highlights a resistant case of 
TTP that presented with concomitant severe rhabdomyolysis, which demanded aggressive, 
continuous intervention.
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Introduction
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder classically 
presenting with fever, thrombocytopenia, microangiopathic hemolytic anemia, renal 
dysfunction, and neurological impairment as well as various multiorgan complications 
and a mortality rate reaching 95% for untreated cases.1 The survival rate is 80%–90% 
with early diagnosis and treatment with plasma infusion and plasma exchange. This 
paper presents a unique case of resistant TTP with severe rhabdomyolysis.
Case report
A 39-year-old Sudanese male presented to the emergency room with fever, jaundice, 
and decreasing level of consciousness (inability to recognize relatives) for 7 days. 
There were no associated symptoms or past medical history. The following laboratory 
values were obtained: white blood cell (WBC) count, 8.6 × 109/L; hemoglobin (Hb), 
67 g/L; platelet (PLT) count, 8 × 109/L; creatinine, 121 µmol/L; prothrombin time and 
partial thromboplastin time, normal; lactate dehydrogenase level (LDH), 1947 U/L; 
increased reticulocyte count; and blood smear showing schistocytes. A urine analysis 
showed the following: blood, +4; pH 5.5; protein, +2; red blood cell count, 15–20; WBC 
count, 1; and specific gravity, 1.0170. The presence of microangiopathic hemolytic 
anemia, thrombocytopenic purpura, neurologic abnormalities, fever, and renal disease 
confirmed the patient’s diagnosis.
The patient was admitted with a presumptive diagnosis of TTP for plasma exchange. 
He received a total of 28 sessions of plasmapheresis. His LDH level decreased to 534 U/L, International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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Hb increased to 87 g/L, and PLT count increased to 36 × 109/L. 
Ten days later, his LDH rose to 1270 U/L, with Hb of 105 g/L 
and PLT count of 14 × 109/L. The patient was started on vin-
cristine and rituximab with a high dose of dexamethasone. The 
patient was also started on cryoprecipitate supernatant because 
of the suboptimal response to plasmapheresis with fresh frozen 
plasma. This was thought to be a relapse of TTP; the condi-
tion was considered and managed as resistant TTP. Two days 
later, intravenous immunoglobulin (full dose) was started. 
Despite the treatment for resistant TTP, the patient worsened, 
requiring ICU (intensive care unit) admission because of the 
development of uncontrolled seizures, which required intuba-
tion and ventilation. The patient developed left-sided weakness 
and hypotension. He was started on vasopressors. Treatment 
with antibiotics and then antifungal therapy commenced; the 
case was labeled as refractory TTP. Repeated brain computed 
tomography scans were normal.
During this process, the creatinine kinase (CK) levels 
increased to .50,000 U/L, with worsening kidney function 
and decreased urine output. Acute renal failure in this patient 
was diagnosed according to the RIFLE (risk, injury, failure, 
loss, end stage) criteria: a rise in creatinine of more than three-
fold, and urine output , 0.3 mL/kg/h over 24 hours. Urine 
alkalanization was started when creatine phosphokinase 
(CPK) started rising to a target urine pH of 8, with several 
fluid boluses targeting a urine output of .200 mL/h. Mannitol 
was used for 24 hours only. The serum calcium concentra-
tion was monitored on a daily basis throughout the patient’s 
stay in the ICU and after his discharge to a step-down unit. 
Continuous venovenous hemodialysis started, although the 
CPK levels did not decrease for 5 days. After maintaining the 
patient on dialysis for 2 weeks, the patient started to improve 
clinically and was more alert, with a CK level of 5360 U/L 
and PLT count of 95 × 109/L (see Figure 1).
All possible differential diagnoses for rhabdomyolysis 
were investigated, including metabolism, viral serology, 
bacterial levels, toxins, and drugs. Compartment syndrome 
was ruled out because of the sustained CPK release.
The difficulty in weaning the patient from the ventilator 
stemmed from critical illness polyneuropathy and the con-
sequences of the tracheostomy. The patient was eventually 
weaned from the ventilator. He was conscious and alert, with 
residual weakness/paresis of the lower limbs, which was 
managed with physiotherapy. The patient continued to require 
intermittent hemodialysis thrice every week.
Discussion
Rhabdomyolysis is most often caused by muscular trauma 
or crush injuries. Other types of causative injuries are non-
traumatic and exertional or nontraumatic and nonexertional. 
Potential causes include malignant hyperthermia, neuroleptic 
malignant syndrome, near drowning/hypothermia, HIV 
(human immunodeficiency virus) infection, snake bites, 
heritable muscle enzyme deficiencies, metabolic and inflam-
matory myopathies, status epilepticus, status asthmaticus, 
eclampsia, prolonged labor, alcohol and cocaine abuse,   copper 
sulfate, zinc phosphide, and other drugs. Traumatic and non-
traumatic causes of rhabdomyolysis have been described in 
other reviews.2,3 Acute renal failure in rhabdomyolysis can 
be attributed to many mechanisms, such as precipitated myo-
globin that blocks the renal tubules, oxygen free-radical 
injury, and renal arteriolar vasoconstriction induced by 
  myoglobin. Acidic urine precipitates myoglobin into casts 
that can occlude the renal tubules, which blocks urine flow 
or output. The other mechanism of renal cellular injury 
is the peroxidation of lipids in the cellular membrane 
by the oxygen free radicals produced by iron-containing 
heme.   Rhabdomyolysis releases platelet-activating factor, 
  endothelin, and prostaglandins, which cause vasoconstriction 
and affect the glomerular filtration rate.4
In this particular case, the cause of resistant, sustained 
rhabdomyolysis could be multifactorial, related most directly 
to the muscle necrosis caused by a microthrombotic process 
secondary to TTP. Rare reports have cited hematological fac-
tors in association with or as the cause of rhabdomyolysis.5 
In this patient, TTP was diagnosed based on the presence of 
thrombocytopenia, microangiopathic hemolytic anemia, and 
central neurological dysfunction. The patient developed resis-
tant rhabdomyolysis, which caused renal failure.   Notably, 
rhabdomyolysis is implicated as the cause of approximately 
5%–25% of cases of acute renal failure.6 There are two 
case reports in the literature worth mentioning. The first 
describes a patient with polymyositis who developed TTP, 
acute renal failure, and rhabdomyolysis after a flare-up of 
polymyositis following radiation therapy administered for 
uterine cervical cancer.7 The second case was a patient with 
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Figure 1 Daily alteration of creatine, CPK, and Ca in association with CVVHD.
Abbreviations:  Ca,  calcium;  CPK,  creatine  phosphokinase;  Crea,  creatine; 
CVVHD, continuous venovenous hemodialysis.International Journal of General Medicine
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thrombotic microangiopathy who presented with fulminant 
  rhabdomyolysis and multiorgan failure. Thrombotic microan-
giopathy typically presents as fulminating rhabdomyolysis 
with multiorgan dysfunction.5
Although the patient developed multiorgan failure with 
TTP and severe sepsis, aggressive and continuous interven-
tions including plasma exchange, chemotherapy, antibiot-
ics, and continuous dialysis all contributed to the patient’s 
recovery, despite the lengthy stay in the ICU.
Conventional treatment for TTP, including plasma 
exchange, was not effective in isolation. When combined with 
chemotherapy and steroid therapy, this approach facilitated 
recovery.8
In conclusion, early, proper treatment of TTP can reduce 
morbidity and mortality in such patients when administered 
in combination with the early introduction of interventions 
such as continuous dialysis, even after the normalization of 
kidney function. This very rare or less recognized presenta-
tion of a rare disease could contribute to a high mortality 
rate if not recognized and treated expediently. This case also 
underlines the importance of reevaluation or reassessment. 
Finally, it is important to note that the acute renal failure 
was persistent, possibly because of rhabdomyolysis and not 
because of TTP alone.
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